BeStock  
Stocks › Biotechnology › FTRE

Fortrea Holdings FTRE

US equityMarket cap rank #2754Biotechnology
$18.55 −$1.60 (-7.94%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $18.55 0.00%
Open$19.89
Prev close$20.15
Day range$18.30 – $20.52
Volume1.54M
Market cap$1.79B
P/E (TTM)–
Dividend yield–

Earnings

Average move on report day±13.4%last 14 reports
Closed higher6 of 1443% of the time
Best reaction+30.2%
Worst reaction-25.1%

Stock move on the day after each report

-1.1%2023/Q4-14.9%2024/Q1-20.3%2024/Q2+30.2%2024/Q3-25.1%2024/Q4-15.6%2025/Q1+0.3%2025/Q2+23.2%2025/Q3+4.4%2025/Q4+18.6%2026/Q1-1.4%2026/Q2-10.6%2026/Q3
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q329 Oct 2026Pre Market±17.1%-10.61%Within range
2026/Q229 Jul 2026Pre Market±17.3%-1.45%Within range
2026/Q15 May 2026Pre Market±19.0%+18.61%Within range
2025/Q426 Feb 2026Pre Market±20.1%+4.45%Within range
2025/Q35 Nov 2025Pre Market±22.4%+23.20%Bigger than priced
2025/Q26 Aug 2025Pre Market±30.4%+0.30%Within range
2025/Q112 May 2025Pre Market±23.3%-15.61%Within range
2024/Q43 Mar 2025Pre Market±21.2%-25.05%Bigger than priced
2024/Q38 Nov 2024Pre Market±22.0%+30.19%Bigger than priced
2024/Q212 Aug 2024Pre Market±16.3%-20.35%Bigger than priced
2024/Q113 May 2024Pre Market±16.1%-14.90%Within range
2023/Q411 Mar 2024Pre Market±12.6%-1.14%Within range
2023/Q313 Nov 2023Pre Market±10.6%+9.61%Within range
2023/Q214 Aug 2023Pre Market±12.4%-12.21%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Latest reported quarter: Q3, ended Sep 2026

Revenue$691.50M-1.4% YoY
Operating profit$15.70M+524.3% YoY
Net profit$600,000.00+103.8% YoY
Diluted EPS$0.01+105.9% YoY
Free cash flow$52.50M-34.0% YoY
Operating cash flow$60.80M

Revenue, last 8 quarters

$697.0MDec '24$651.3MMar '25$710.3MJun '25$701.3MSep '25$660.5MDec '25$636.5MMar '26$678.2MJun '26$691.5MSep '26

Net profit, last 8 quarters

$-61.2MDec '24$-562.9MMar '25$-374.9MJun '25$-15.9MSep '25$-32.5MDec '25$-23.6MMar '26$-13.2MJun '26$600.0KSep '26

Profitability & balance sheet

Gross margin20.0%
Operating margin1.7%
Net margin-2.6%
Return on equity-12.3%
Return on assets-2.5%
Return on invested capital-1.1%
Current ratio0.97
Liabilities / assets80.6%
Cash & investments$220.60M
Total debt$1.11B
Net cash (debt)-$888.50M
Free cash flow / sales6.3%

Discussion

No comments yet — be the first to weigh in on FTRE.

Sign in to join the discussion.

Scroll to Top